Chronic Alcohol Consumption Disrupted Cholesterol Homeostasis in Rats: Down-regulation of Low-density Lipoprotein Receptor and Enhancement of Cholesterol Biosynthesis Pathway in the Liver

Overview

Journal Alcohol Clin Exp Res

Specialty Psychiatry

Date 2009 Dec 24

PMID 20028367

Citations 44

Authors

Zhigang Wang

Tong Yao

Zhenyuan Song

Affiliations

Soon will be listed here.

Abstract

Background: Chronic alcohol consumption causes alcoholic liver disease, which is associated, or initiated, with dysregulated lipid metabolism. Very recent evidence suggested that dysregulated cholesterol metabolism plays an important role in the pathogenesis of alcoholic fatty liver diseases, however, the effects of chronic alcohol exposure on cholesterol homeostasis have not been well studied and underlying mechanisms behind are still elusive.

Methods: Male Sprague-Dawley rats weighing 250 +/- 5.5 g (mean +/- SEM) divided into 2 groups (8 rats per group) and pair-fed with liquid diets containing (in percent of energy intake) 18% protein, 35% fat, 12% carbohydrate, and 35% either ethanol (ethanol diet) or an isocaloric maltose-dextrin mixture (control diet), according to Lieber and De Carli, for 4 weeks.

Results: Long-term excessive alcohol feeding to rats caused fatty liver and liver injury, which was associated with disrupted cholesterol homeostasis, characterized by increased hepatic cholesterol levels and hypercholesterolemia. Hepatic cholesterol increases were concomitant with constantly activated sterol regulatory element-binding protein-2 (SREBP-2) in the liver and increased expression of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, a rate-limiting enzyme for cholesterol de novo synthesis, indicating enhanced cholesterol biosynthesis. Alcohol-induced hypercholesterolemia was accompanied by decreased LDL receptor (LDLr) levels in the liver. Further investigations revealed that chronic alcohol exposure increased hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) contents to down-regulate LDLr via a post-translational mechanism. Moreover, alcohol feeding suppressed extracellular signal-regulated kinase (ERK) activation in the liver. In vitro studies showed that inhibition of ERK activation was associated with decreased LDLr expression in HepG2 cells.

Conclusions: Our study provides the first evidence that both increased PCSK9 expression and suppressed ERK activation in the liver contributes to alcohol-induced hypercholesterolemia in rats.

Citing Articles

Hepatoprotective Effect of Mycelium Powder on Alcohol-Induced Liver Damage.

Kim U, Jang S, Chen P, Horii S, Wen W Nutrients. 2024; 16(19).

PMID: 39408373 PMC: 11478381. DOI: 10.3390/nu16193406.

Synthesis of Ganoderic Acids Loaded Zein-Chitosan Nanoparticles and Evaluation of Their Hepatoprotective Effect on Mice Given Excessive Alcohol.

Cao Y, Yang Y, Liang Z, Guo W, Lv X, Ni L Foods. 2024; 13(17).

PMID: 39272525 PMC: 11394847. DOI: 10.3390/foods13172760.

Enlarged perivascular spaces in alcohol-related brain damage induced by dyslipidemia.

Liu H, Meng L, Wang J, Qin C, Feng R, Chen Y J Cereb Blood Flow Metab. 2024; 44(10):1867-1880.

PMID: 38700501 PMC: 11494831. DOI: 10.1177/0271678X241251570.

Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease.

Rastovic U, Bozzano S, Riva A, Simoni-Nieves A, Harris N, Miquel R Int J Mol Sci. 2024; 25(1).

PMID: 38203321 PMC: 10778645. DOI: 10.3390/ijms25010150.

Chronic-binge ethanol feeding aggravates systemic dyslipidemia in mice, thereby accelerating hepatic fibrosis.

Hoebinger C, Rajcic D, Silva B, Hendrikx T Front Endocrinol (Lausanne). 2023; 14:1148827.

PMID: 37560305 PMC: 10407564. DOI: 10.3389/fendo.2023.1148827.

References

Menon K, Gores G, Shah V . Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc. 2001; 76(10):1021-9. DOI: 10.4065/76.10.1021. View

Rashid S, Curtis D, Garuti R, Anderson N, Bashmakov Y, Ho Y . Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A. 2005; 102(15):5374-9. PMC: 556275. DOI: 10.1073/pnas.0501652102. View

Chait A, Mancini M, February A, Lewis B . Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet. 1972; 2(7767):62-4. DOI: 10.1016/s0140-6736(72)91552-8. View

Lluis J, Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Checa J . Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology. 2003; 124(3):708-24. DOI: 10.1053/gast.2003.50089. View

Nakahara M, Fujii H, Maloney P, Shimizu M, Sato R . Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA. J Biol Chem. 2002; 277(40):37229-34. DOI: 10.1074/jbc.M206749200. View

Lefevre A, DECARLI L, Lieber C . Effect of ethanol on cholesterol and bile acid metabolism. J Lipid Res. 1972; 13(1):48-55. View

Attie A, Seidah N . Dual regulation of the LDL receptor--some clarity and new questions. Cell Metab. 2005; 1(5):290-2. DOI: 10.1016/j.cmet.2005.04.006. View

Kang S, Davis R . Cholesterol and hepatic lipoprotein assembly and secretion. Biochim Biophys Acta. 2000; 1529(1-3):223-30. DOI: 10.1016/s1388-1981(00)00151-7. View

Fischer M, You M, Matsumoto M, Crabb D . Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem. 2003; 278(30):27997-8004. DOI: 10.1074/jbc.M302140200. View

10.

Kharbanda K, Todero S, Ward B, Cannella 3rd J, Tuma D . Betaine administration corrects ethanol-induced defective VLDL secretion. Mol Cell Biochem. 2009; 327(1-2):75-8. DOI: 10.1007/s11010-009-0044-2. View

11.

Chang T, Chang C, Ohgami N, Yamauchi Y . Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol. 2006; 22:129-57. DOI: 10.1146/annurev.cellbio.22.010305.104656. View

12.

Konig B, Koch A, Spielmann J, Hilgenfeld C, Stangl G, Eder K . Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol. 2006; 73(4):574-85. DOI: 10.1016/j.bcp.2006.10.027. View

13.

Fernandez A, Colell A, Garcia-Ruiz C, Fernandez-Checa J . Cholesterol and sphingolipids in alcohol-induced liver injury. J Gastroenterol Hepatol. 2008; 23 Suppl 1:S9-15. DOI: 10.1111/j.1440-1746.2007.05280.x. View

14.

Park S, Moon Y, Horton J . Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem. 2004; 279(48):50630-8. DOI: 10.1074/jbc.M410077200. View

15.

Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F . SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004; 86(11):839-48. DOI: 10.1016/j.biochi.2004.09.018. View

16.

BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

17.

Hobbs H, Brown M, Goldstein J . Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992; 1(6):445-66. DOI: 10.1002/humu.1380010602. View

18.

Abidi P, Zhou Y, Jiang J, Liu J . Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol. 2005; 25(10):2170-6. DOI: 10.1161/01.ATV.0000181761.16341.2b. View

19.

Dubuc G, Chamberland A, Wassef H, Davignon J, Seidah N, Bernier L . Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2004; 24(8):1454-9. DOI: 10.1161/01.ATV.0000134621.14315.43. View

20.

You M, Crabb D . Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1):G1-6. DOI: 10.1152/ajpgi.00056.2004. View